Novel methodologies for biomarker discovery in atherosclerosis - Wikidata - wikimedia - TriplyDB

Novel methodologies for biomarker discovery in atherosclerosis

Novel methodologies for biomarker discovery in atherosclerosis

http://www.wikidata.org/entity/Q28088373

about

The year in cardiology 2015: prevention Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.Prediction of acute coronary syndromes by urinary proteome analysis.Protective effects of sirtuins in cardiovascular diseases: from bench to bedside High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study Low MT-CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease.Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands.Level of FABP3, FABP4, Nt-proBNP and Total Cardiovascular Risk in the Population of Central Kazakhstan.New and emerging biomarkers in cardiovascular disease.Extracellular microvesicle microRNAs in children with sickle cell anaemia with divergent clinical phenotypes.Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences.Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?Lipidomics in the Study of Hypertension in Metabolic Syndrome.The immunology of atherosclerosis.Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma.Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review.Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies.* Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia.Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy.Epigenetics and Immunometabolism in Diabetes and Aging.Detecting human coronary inflammation by imaging perivascular fat.Extracellular Vesicles in Cardiovascular Theranostics.Association of ficolin-3 with abdominal aortic aneurysm presence and progression.Assessment of the Procoagulant Activity of Microparticles and the Protein Z System in Patients Undergoing Off-Pump Coronary Artery Bypass Surgery.Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential.Stromal Cell-Derived Factor-1 Alpha Is Decreased in Women With Migraine With Aura.High-density lipoprotein (HDL) and infections: a versatile culprit.Nontraditional Cardiovascular Biomarkers and Risk Factors: Rationale and Future Perspectives.Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics Novel Multiomics Profiling of Human Carotid Atherosclerotic Plaques and Plasma Reveals Biliverdin Reductase B as a Marker of Intraplaque Hemorrhage

P2860

Q28072221-B886E301-A92A-4B4F-AFD2-C912D53EA57C Q31082889-EE7EF163-F654-4F14-89E1-55EB317FCF5F Q36300622-A4C3F87C-1063-4229-9729-EB2FBE5E5CAF Q36387714-F291BB81-71EF-4A2D-8BA4-D57AEE3EF707 Q37149945-B495A8CD-FF2D-4123-B5CC-CBF68F4BF67C Q37472354-38D8F310-5956-46F7-A316-3CF8C833D134 Q37556409-BF2AD5AD-4FFC-4DCC-A4A1-2D60E54A9F79 Q37576804-92031992-8894-4753-A883-695DD3D04F97 Q37658760-54404EFC-5078-4AC1-8E3C-7EB8559358B5 Q38586900-62F7A1C0-C436-48A7-BDED-E87A28783C1E Q38772122-9E378ADF-775B-43B1-BBB7-13496D82BBD8 Q38803730-7A4CAD06-E76B-4EC7-959B-2627ADEE130E Q38813514-57E0C231-8B3A-494A-A6A1-F3BF1CFD8D32 Q39123802-44191D59-25CB-49A1-8CE7-96C5991AAF91 Q39230390-CDD042AA-683E-401C-BF57-2C7EE801D6BF Q40310560-4F99C0E3-B458-44F1-85CB-C1136D9F3876 Q41595498-FA524AC9-5B52-4D36-81B8-BA3B9D3E3BFE Q41712425-66A2320D-E95D-4CE5-AC27-B45BE35B5455 Q46268171-422FB439-D9FD-441D-8FA0-07F150558F07 Q47153055-F4A33A6D-5ED9-4692-A4EA-E3E9EF1AEB9F Q47652764-70AD8BA8-F2E2-4C4F-90E6-C7FB8AE5EE7E Q47933631-41966D92-26E1-439A-987A-16728D1B42C3 Q47935740-B23FE939-388E-447C-A7C6-AF2FA99CC543 Q47955532-32D006DA-C4E7-44DF-AC51-88905EFAE469 Q48136703-BEAC19CC-1C4B-4C00-903F-2EB629614DEE Q49196893-EF4AA517-5C57-42D0-96C3-E70B71097833 Q50220179-C609FE6B-E5DC-49BC-BC2A-4F7CFC2FB5B6 Q51024042-796667C7-29C2-4C87-9463-FCA9D54BFDAE Q51615648-5BAE5239-292E-4B72-8D99-4886597136EA Q52851758-70C93B16-FA4D-4AC2-9E54-039A8B999AEF Q54301043-B72ACA29-D4D2-48F3-8C1E-64A775DCC713 Q55384368-8BE708C5-68A9-47A8-8514-199928F09AAB Q56978474-16717850-F7D4-41F8-AC55-4820858301F6 Q58805141-CDC82413-39AC-4ADD-8872-D6DB160FA85E

P2860

Novel methodologies for biomarker discovery in atherosclerosis

http://www.wikidata.org/entity/Q28088373

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Novel methodologies for biomarker discovery in atherosclerosis

@ast

Novel methodologies for biomarker discovery in atherosclerosis

@en

Novel methodologies for biomarker discovery in atherosclerosis

@nl

type

label

Novel methodologies for biomarker discovery in atherosclerosis

@ast

Novel methodologies for biomarker discovery in atherosclerosis

@en

Novel methodologies for biomarker discovery in atherosclerosis

@nl

prefLabel

Novel methodologies for biomarker discovery in atherosclerosis

@ast

Novel methodologies for biomarker discovery in atherosclerosis

@en

Novel methodologies for biomarker discovery in atherosclerosis

@nl

P1433

Q28088373-E761C0EE-4349-4573-AFDA-17761DB64608

P1476

Q28088373-0FE55EC1-FB3A-4900-B7F0-48AF352A0A24

P2093

Q28088373-079617A7-C0C7-4CDF-A9E3-CEB2EAEA7F99

Q28088373-0BABA6F6-3E9C-4727-A0B1-0BE0CFA38916

Q28088373-37E39C2E-E05E-431D-B0AE-BCB47677B6F7

Q28088373-7E44AB29-EE54-4B42-B3EF-0DF1BB2A04D3

Q28088373-84CA8A7C-427C-4A61-888D-7CE8FB44D8B0

Q28088373-B75A4C06-15D9-4BFF-8AF6-D240C9F5920C

Q28088373-C88B997E-ED14-4AFC-A1A1-66C438889C93

P2860

Q28088373-012E9AD9-25BA-4EC8-AACE-5353F7242489

Q28088373-018A7331-71F9-43C9-B586-8216A5CF805E

Q28088373-0210EC51-5A74-4A75-A1AC-C0024BCAD965

Q28088373-021F699C-4560-4132-A79E-17D1BDBE9A91

Q28088373-025B59A4-F2A4-46C6-A527-1884B6888F1D

Q28088373-04E2D10F-2203-406C-A63C-6690398B56A7

Q28088373-06B13C9C-60C0-49DC-8648-13F548C68D78

Q28088373-0A72119A-BDCA-450E-BD1F-C1EDC2456934

Q28088373-0A88E243-FB2E-41C3-875D-F47727E5D498

Q28088373-0DBE5E99-8AE0-4B13-A2D6-E58EC3C4BA23

P304

Q28088373-2CBF0696-3B90-4911-B27E-897C2DB5D5A0

P31

Q28088373-2DCD105E-D33A-46F4-81A6-5F134A8CAF6D

P356

Q28088373-C7A6B794-B40E-488F-9960-FB7097BDDFF4

P407

Q28088373-12871121-84A4-4C0A-BE3E-7D5653E2C4EE

P433

Q28088373-0241BED6-2CC8-4A54-9227-DCABA910F07B

P478

Q28088373-3654C209-09F4-4BC0-B89C-FBA3B4F72D93

P50

Q28088373-33CCF516-E117-4365-AFFA-3684624E9B52

Q28088373-350C5D5E-5ED6-465E-87D5-816C3FEA0855

Q28088373-422D184F-663C-4813-B5A7-BD5B95FE3224

Q28088373-46D9A239-1744-4FA2-958E-9340ECF1662C

Q28088373-57AEC3F0-08A9-43FD-8180-12BE639A9253

Q28088373-90A6637C-3D66-431F-BD10-FD0913A5FD72

Q28088373-9D187E24-7889-42CE-ACC4-808BC1B58176

Q28088373-BDE6F8F7-41DF-4FB5-801C-75D034FE081B

Q28088373-C5D043AA-46FD-4230-B6A9-21FBD3D66453

Q28088373-CE33B15D-2EFD-4223-B4E7-C11F2D0FF27C

P577

Q28088373-8CD2F601-CAE9-4CD3-8F52-85BCED829105

P5875

Q28088373-47A22A37-0152-4D10-8B7E-E370569A092B

P698

Q28088373-CD586C35-F5F5-486E-B0FE-F5CB2F18E0ED

P921

Q28088373-AFDC6E75-7AAF-4A69-B447-313FF3F36908

Q28088373-DE932870-5609-467C-94CD-380FC2FCA7E7

P356

P1433

European Heart Journal

P1476

Novel methodologies for biomarker discovery in atherosclerosis

@en

P2093

Brenda R. Kwak

http://www.w3.org/2001/XMLSchema#string

Imo E. Hoefer

http://www.w3.org/2001/XMLSchema#string

Jesus Egido

http://www.w3.org/2001/XMLSchema#string

Jose Tuñón

http://www.w3.org/2001/XMLSchema#string

Marie-Luce Bochaton-Piallat

http://www.w3.org/2001/XMLSchema#string

Paul C. Evans

http://www.w3.org/2001/XMLSchema#string

Tomasz Guzik

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

Lipidomics reveals a remarkable diversity of lipids in human plasma

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

The human plasma lipidome

P304

2635-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHV236

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Stefanie Dimmeler

Mika Ala-Korpela

Christian Weber

Chantal M Boulanger

Gerard Pasterkamp

P577

2015-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279157742

http://www.w3.org/2001/XMLSchema#string

P698

26049157

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis